RLYB Rallybio Corporation - Common Stock
$17,10
Prix · Aoû 19, 2026
Données fondamentales au Aoû 6, 2026
Fourchette 52 semaines
$0–$18
97% of range
Note des analystes
HOLD
6 analysts
Objectif de cours
—
P/E (TTM)
-10.8
ROE
-17.3%
Marge nette
-1046.4%
RLYB Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$17.10
Capitalisation Boursière
$90M
P/E (TTM)
-10.8
BPA (TTM)
$-1.59
Revenus (TTM)
$858.0K
Rendement div.
—
ROE
-17.3%
Dette/Capitaux propres
—
Fourchette 52 semaines
$0 – $18
RLYB Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$858.0K
2024-12-31
→
2025-12-31
BPA
$-1.59
2021-12-31
→
2025-12-31
Flux de trésorerie libre
—
2021-12-31
→
2024-12-31
Marges
-1046.4%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
RLYB
Médiane des pairs
P/E (TTM)
-10.8
0.8
P/S (TTM)
105.3
2.2
P/B
1.6
2.3
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
RLYB
Médiane des pairs
Operating Margin (Marge d'exploitation)
-3853.6%
—
Net Profit Margin (Marge nette)
-1046.4%
-177.6%
ROA
-13.8%
-39.2%
ROE
-17.3%
-63.0%
ROIC
-57.0%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
RLYB
Médiane des pairs
Current Ratio (Ratio de liquidité)
14.5
3.9
Quick Ratio (Ratio de liquidité réduite)
13.0
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
RLYB
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
34.9%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
RLYB
Médiane des pairs
RLYB Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
VENTE
6 analystes
- Achat fort 0 0,0%
- Achat 0 0,0%
- Conserver 3 50,0%
- Vente 1 16,7%
- Vente forte 2 33,3%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.26%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-1.46 | $-1.22 | -0.24% |
| 31 décembre 2025 | $-1.03 | $-1.20 | 0.17% |
| 30 septembre 2025 | $-1.12 | $-1.75 | 0.63% |
| 30 juin 2025 | $-1.76 | $-2.00 | 0.24% |
| 31 mars 2025 | $-1.68 | $-2.12 | 0.44% |
| 31 décembre 2024 | $-2.00 | $-2.34 | 0.34% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | — |
| ALDX | $312M | -9.2 | — | — | -68.0% | — |
| KLRS | $193M | -3.0 | — | — | -65.8% | — |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | — |
| ACRV | $76M | -1.2 | — | — | -61.0% | — |
| ICCC | — | -51.2 | 4.3% | — | — | — |
| GANX | $135M | -5.3 | -60.6% | — | -181.1% | — |
| ACET | — | -0.5 | — | — | — | — |
| ELTX | — | -3.1 | — | — | — | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue | $858.0K | $636.0K | |
| R&D Expense | $20M | $42M | |
| SG&A Expense | $14M | $20M | |
| Operating Expenses | $34M | $61M | |
| Operating Income | $-33M | $-60M | |
| Other Non-op | $23M | $744.0K | |
| Pretax Income | $-9M | $-56M | |
| Income Tax | $0 | $0 | |
| Net Income | $-9M | $-58M | |
| EPS (Basic) | $-1.59 | $-10.61 | |
| EPS (Diluted) | $-1.59 | $-10.61 | |
| Shares (Basic) | 5,629,370 | 5,443,332 | |
| Shares (Diluted) | 5,629,370 | 5,443,332 | |
| EBITDA | $-33M | $-60M |
Bilan 22
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $31M | $14M | |
| Short-term Investments | $23M | $52M | |
| Prepaid Expense | $7M | $2M | |
| Other Current Assets | $3M | $995.0K | |
| Current Assets | $61M | $68M | |
| PP&E (Net) | $23.0K | $115.0K | |
| PP&E (Gross) | $503.0K | $769.0K | |
| Accum. Depreciation | $480.0K | $654.0K | |
| Other Non-current Assets | $810.0K | $0 | |
| Total Assets | $62M | $68M | |
| Accounts Payable | $126.0K | $278.0K | |
| Accrued Liabilities | $4M | $5M | |
| Current Liabilities | $4M | $6M | |
| Capital Leases | $82.0K | $0 | |
| Total Liabilities | $4M | $6M | |
| Common Stock | $4.0K | $4.0K | |
| Paid-in Capital | $360M | $355M | |
| Retained Earnings | $-302M | $-293M | |
| AOCI | $18.0K | $68.0K | |
| Stockholders' Equity | $58M | $62M | |
| Liabilities + Equity | $62M | $68M | |
| Shares Outstanding | 5,283,321 | 5,188,743 |
Flux de trésorerie 10
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| D&A | $92.0K | $131.0K | |
| Stock-based Comp | $5M | $8M | |
| Operating Cash Flow | $-30M | $-49M | |
| CapEx | · | $0 | |
| Investing Cash Flow | $47M | $33M | |
| Stock Issued | $0 | $5M | |
| Net Stock Activity | $0 | $5M | |
| Financing Cash Flow | $16.0K | $5M | |
| Net Change in Cash | $17M | $-11M | |
| Free Cash Flow | · | $-49M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -3853.6% | -10082.7% | |
| Net Margin | -1046.4% | -9629.2% | |
| Pretax Margin | -1046.4% | -9256.0% | |
| EBITDA Margin | -3853.6% | -10082.7% | |
| ROA | -13.8% | -62.9% | |
| ROE | -17.3% | -87.2% | |
| ROIC | -57.0% | -98.1% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 14.5 | 10.9 | |
| Quick Ratio | 13.0 | 10.5 |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Taux de croissance 1
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 34.9% | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $858.0K | $636.0K | |
| Net Income TTM | $-9M | $-58M | |
| Market Cap | $4M | $40M | |
| P/E | -0.4 | -0.1 | |
| P/S | 4.2 | 62.7 | |
| P/B | 0.1 | 0.6 | |
| P / Tangible Book | 0.1 | 0.6 | |
| P / Cash Flow | -0.1 | -0.8 | |
| P / FCF | · | -0.8 | |
| Earnings Yield | -231.8% | -1105.2% |
Compte de résultat 14
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $212.0K | $222.0K | $212.0K | $212.0K | $212.0K | $38.0K | $299.0K | $299.0K | $0 | · | $0 | $0 | |
| R&D Expense | $758.0K | $3M | $4M | $4M | $6M | $6M | $7M | $8M | $13M | $13M | $16M | $13M | $13M | |
| SG&A Expense | $5M | $6M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $7M | $5M | $6M | $7M | |
| Operating Expenses | $6M | $9M | $7M | $7M | $10M | $10M | $12M | $12M | $17M | $20M | $21M | $19M | $20M | |
| Operating Income | $-6M | $-9M | $-6M | $-7M | $-10M | $-10M | $-12M | $-12M | $-17M | $-20M | $-21M | $-19M | $-20M | |
| Other Non-op | $424.0K | $254.0K | $0 | $22M | $118.0K | $174.0K | $183.0K | $251.0K | $143.0K | $167.0K | $35.0K | $92.0K | $62.0K | |
| Pretax Income | $45M | $-8M | $-7M | $16M | $-9M | $-9M | · | $-11M | $-16M | $-18M | $-20M | $-18M | $-18M | |
| Income Tax | $1M | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $44M | $-8M | $-6M | $16M | $-10M | $-9M | $-11M | $-11M | $-16M | $-19M | $-20M | $-18M | $-19M | |
| EPS (Basic) | $7.66 | $-1.46 | $-1.52 | $0.36 | $-1.73 | $-1.69 | $-9.51 | $-0.26 | $-0.37 | $-0.47 | $-0.50 | $-0.45 | $-0.46 | |
| EPS (Diluted) | $7.53 | $-1.46 | $-1.52 | $0.36 | · | $-1.69 | $-9.51 | $-0.26 | $-0.37 | $-0.47 | $-0.50 | $-0.45 | $-0.46 | |
| Shares (Basic) | 5,699,111 | 5,688,584 | -129,044,963 | 45,058,591 | 5,605,116 | 5,597,528 | -124,051,563 | 44,593,221 | 44,128,059 | 40,773,615 | -80,696,904 | 40,531,497 | 40,363,902 | |
| Shares (Diluted) | 5,797,913 | 5,688,584 | -129,044,963 | 45,058,591 | · | 5,597,528 | -124,051,563 | 44,593,221 | 44,128,059 | 40,773,615 | -80,696,904 | 40,531,497 | 40,363,902 | |
| EBITDA | $-6M | $-9M | · | $-7M | $-10M | $-10M | · | $-12M | $-17M | $-20M | · | $-19M | $-20M |
Bilan 22
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $41M | $31M | $32M | $9M | $15M | $14M | $25M | $17M | $19M | $24M | $19M | $33M | |
| Short-term Investments | $0 | $5M | $23M | $27M | $36M | $40M | $52M | $50M | $72M | $75M | $85M | $102M | $105M | |
| Prepaid Expense | $4M | $7M | $7M | $7M | $5M | $3M | $2M | $3M | $3M | $4M | $5M | $11M | $9M | |
| Other Current Assets | $4M | $6M | $3M | $3M | $573.0K | $872.0K | $995.0K | $2M | $1M | $768.0K | $2M | $4M | $1M | |
| Current Assets | $97M | $53M | $61M | $67M | $50M | $57M | $68M | $78M | $91M | $99M | $115M | $132M | $147M | |
| PP&E (Net) | $0 | $20.0K | $23.0K | $26.0K | $61.0K | $87.0K | $115.0K | $145.0K | $177.0K | $211.0K | $246.0K | $282.0K | $308.0K | |
| PP&E (Gross) | · | · | $503.0K | · | · | · | $769.0K | · | · | · | $769.0K | · | · | |
| Accum. Depreciation | · | · | $480.0K | · | · | · | $654.0K | · | · | · | $523.0K | · | · | |
| Other Non-current Assets | $810.0K | $810.0K | $810.0K | $810.0K | · | · | $0 | · | · | · | · | · | · | |
| Total Assets | $98M | $54M | $62M | $68M | $51M | $58M | $68M | $79M | $92M | $99M | $116M | $133M | $148M | |
| Accounts Payable | $833.0K | $940.0K | $126.0K | $269.0K | $119.0K | $400.0K | $278.0K | $583.0K | $1M | $470.0K | $976.0K | $464.0K | $689.0K | |
| Accrued Liabilities | $1M | $3M | $4M | $4M | $4M | $3M | $5M | $6M | $10M | $9M | $8M | $9M | $7M | |
| Current Liabilities | $4M | $4M | $4M | $5M | $5M | $4M | $6M | $8M | $12M | $10M | $9M | $9M | $8M | |
| Capital Leases | $0 | $55.0K | $82.0K | $108.0K | · | · | $0 | $0 | $58.0K | $116.0K | $173.0K | $211.0K | $266.0K | |
| Total Liabilities | $4M | $4M | $4M | $5M | $5M | $4M | $6M | $8M | $12M | $10M | $9M | $10M | $8M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $361M | $361M | $360M | $359M | $358M | $356M | $355M | $353M | $351M | $343M | $341M | $339M | $336M | |
| Retained Earnings | $-267M | $-310M | $-302M | $-296M | $-312M | $-302M | $-293M | $-282M | $-271M | $-254M | $-235M | $-215M | $-197M | |
| AOCI | $0 | $1.0K | $18.0K | $24.0K | $17.0K | $47.0K | $68.0K | $169.0K | $-71.0K | $-71.0K | $15.0K | $-208.0K | $-272.0K | |
| Stockholders' Equity | $94M | $50M | $58M | $63M | $46M | $54M | $62M | $71M | $80M | $89M | $106M | $124M | $139M | |
| Liabilities + Equity | $98M | $54M | $62M | $68M | $51M | $58M | $68M | $79M | $92M | $99M | $116M | $133M | $148M | |
| Shares Outstanding | 5,306,894 | 5,290,236 | 5,283,321 | 41,935,841 | 41,707,153 | 41,612,039 | 5,188,743 | 41,487,586 | 41,487,586 | 37,811,970 | 37,829,565 | 37,800,856 | 37,790,856 |
Flux de trésorerie 9
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.0K | $3.0K | $3.0K | $35.0K | $26.0K | $28.0K | $30.0K | $32.0K | $34.0K | $35.0K | $36.0K | $37.0K | $38.0K | |
| Stock-based Comp | $424.0K | $613.0K | $774.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| Operating Cash Flow | $46M | $-8M | $-5M | $-7M | $-8M | $-10M | $-10M | $-14M | $-10M | $-15M | $-12M | $-16M | $-13M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $12.0K | $0 | $0 | |
| Investing Cash Flow | $6M | $18M | $4M | $29M | $3M | $11M | $-2M | $22M | $3M | $10M | $17M | $3M | $6M | |
| Stock Issued | · | $3.0K | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $-209.0K | · | |
| Net Stock Activity | · | $3.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $131.0K | $3.0K | $6.0K | $0 | $10.0K | $0 | $18.0K | $-11.0K | $5M | $0 | $72.0K | $0 | $210.0K | |
| Net Change in Cash | $52M | $10M | $-748.0K | $23M | $-5M | $876.0K | $-11M | $9M | $-3M | $-5M | $5M | $-13M | $-7M |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -4119.3% | · | -3266.5% | -4743.9% | -4561.3% | · | -4035.5% | -5697.3% | · | · | · | · | |
| Net Margin | · | -3904.7% | · | 7554.7% | -4576.9% | -4452.4% | · | -3834.8% | -5430.1% | · | · | · | · | |
| Pretax Margin | · | -3904.7% | · | 7554.7% | -4441.5% | -4175.5% | · | -3621.7% | -5267.2% | · | · | · | · | |
| EBITDA Margin | · | -4119.3% | · | -3266.5% | -4743.9% | -4561.3% | · | -4035.5% | -5697.3% | · | · | · | · | |
| ROA | 58.6% | -14.7% | · | 21.8% | -13.5% | -12.0% | · | -10.8% | -13.5% | -14.5% | · | -13.3% | -12.3% | |
| ROE | 62.2% | -15.9% | · | 23.9% | -15.4% | -13.2% | · | -11.8% | -14.8% | -15.6% | · | -14.4% | -13.0% | |
| ROIC | -5.8% | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 27.3 | 12.9 | · | 14.7 | 10.0 | 14.7 | · | 9.6 | 7.5 | 9.8 | · | 14.1 | 18.2 | |
| Quick Ratio | 26.0 | 11.3 | · | 13.1 | 9.1 | 13.9 | · | 9.2 | 7.3 | 9.3 | · | 12.9 | 17.1 |
Efficacité 1
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · |
Valorisation (TTM) 9
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $636.0K | $848.0K | · | $935.0K | $1M | $810.0K | · | $598.0K | $299.0K | · | · | · | · | |
| Net Income TTM | $42M | $-11M | · | $-15M | $-47M | $-56M | · | $-65M | $-72M | $-73M | · | $-73M | $-72M | |
| Market Cap | $85M | $47M | · | $21M | $14M | $27M | · | $49M | $56M | $70M | · | $127M | $214M | |
| P/E | · | -3.0 | · | -1.5 | -0.3 | -0.5 | · | -0.8 | -0.8 | -1.0 | · | -1.7 | -2.7 | |
| P/S | 133.5 | 56.0 | · | 22.4 | 13.8 | 33.6 | · | 81.2 | 185.9 | · | · | · | · | |
| P/B | 0.9 | 0.9 | · | 0.3 | 0.3 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 1.0 | 1.5 | |
| P / Tangible Book | 0.9 | 0.9 | · | 0.3 | 0.3 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 1.0 | 1.5 | |
| P / Cash Flow | · | -5.9 | · | · | · | -2.7 | · | · | · | -4.5 | · | · | · | |
| Earnings Yield | · | -33.6% | · | -66.1% | -313.6% | -200.0% | · | -132.5% | -130.6% | -97.8% | · | -57.6% | -36.4% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $858.0K | $636.0K | — | — | — |
| Marge d'exploitation % | -3853.6% | -10082.7% | — | — | — |
| Résultat net | $-9M | $-58M | $-75M | $-67M | $-47M |
| BPA dilué | $-1.59 | $-10.61 | $-1.84 | $-2.09 | $-1.84 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 14.5 | 10.9 | 12.4 | 16.7 | 27.6 |
| Ratio de liquidité réduite | 13.0 | 10.5 | 11.9 | 15.7 | 26.8 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | — | $-49M | $-60M | $-57M | $-46M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 42 déclarants · $69.2M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 13 | 9 | 7 | 6 | — |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée. Variation par rapport au trimestre précédent non affichée : la couverture des déclarants diffère trop entre ces deux trimestres pour une comparaison fiable.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | $14 821 632 | 926 352 | 21,43% | Actions |
| CITADEL ADVISORS LLC | $11 580 810 | 7 633 807 | 16,74% | Actions |
| VIKING GLOBAL INVESTORS LP | $8 389 552 | 524 347 | 12,13% | Actions |
| TPG GP A, LLC | $6 056 816 | 378 551 | 8,76% | Actions |
| FMR LLC | $5 084 640 | 317 790 | 7,35% | Actions |
| Pivotal bioVenture Partners Investment Advisor LLC | $4 809 264 | 300 579 | 6,95% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $3 198 512 | 199 907 | 4,62% | Actions |
| Nantahala Capital Management, LLC | $3 014 752 | 188 422 | 4,36% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $2 759 952 | 172 497 | 3,99% | Actions |
| Almitas Capital LLC | $1 930 912 | 120 682 | 2,79% | Actions |
| Rangeley Capital, LLC | $1 677 600 | 104 850 | 2,43% | Actions |
| New Leaf Venture Partners, L.L.C. | $1 647 500 | 3 301 603 | 2,38% | Actions |
| AJU IB Investment Co., Ltd. | $846 176 | 94 334 | 1,22% | Actions |
| Mariner, LLC | $809 056 | 50 566 | 1,17% | Actions |
| JANE STREET GROUP, LLC | $541 504 | 33 844 | 0,78% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $407 793 | 25 480 | 0,59% | Actions |
| XTX Topco Ltd | $343 952 | 21 497 | 0,50% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $269 120 | 16 820 | 0,39% | Actions |
| TWO SIGMA INVESTMENTS, LP | $265 904 | 16 619 | 0,38% | Actions |
| STATE STREET CORP | $207 936 | 12 996 | 0,30% | Actions |
| Quadrature Capital Ltd | $207 920 | 12 995 | 0,30% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $180 480 | 11 280 | 0,26% | Actions |
| Vanguard Global Advisers, LLC | $23 072 | 1 442 | 0,03% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $20 000 | 1 250 | 0,03% | Actions |
| TWO SIGMA ADVISERS, LP | $13 242 | 19 300 | 0,02% | Actions |
| Hartford Financial Management Inc. | $12 992 | 812 | 0,02% | Actions |
| BlackRock, Inc. | $12 720 | 795 | 0,02% | Actions |
| SBI Securities Co., Ltd. | $8 096 | 506 | 0,01% | Actions |
| VANGUARD GROUP INC | $7 914 | 11 536 | 0,01% | Actions |
| Caitong International Asset Management Co., Ltd | $6 944 | 434 | 0,01% | Actions |
| UBS Group AG | $2 336 | 146 | 0,00% | Actions |
| Truvestments Capital LLC | $2 064 | 129 | 0,00% | Actions |
| MORGAN STANLEY | $2 000 | 125 | 0,00% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $1 920 | 120 | 0,00% | Actions |
| Fortitude Family Office, LLC | $848 | 53 | 0,00% | Actions |
| WELLS FARGO & COMPANY/MN | $592 | 37 | 0,00% | Actions |
| EverSource Wealth Advisors, LLC | $496 | 31 | 0,00% | Actions |
| HRT FINANCIAL LP | $410 | 25 657 | 0,00% | Actions |
| JPMORGAN CHASE & CO | $145 | 9 | 0,00% | Actions |
| Allworth Financial LP | $96 | 6 | 0,00% | Actions |
| BARCLAYS PLC | $48 | 3 | 0,00% | Actions |
| DANSKE BANK A/S | $16 | 1 | 0,00% | Actions |
Initiés de la société 15 initiés · 5 dirigeants · 10 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Martin Mackay | Chief Executive Officer | 6 février 2023 A | 282 609 | 0 | 0 | $0 |
| Jonathan I Lieber | Chief Financial Officer and Treasurer | 14 mars 2023 P | 5 000 | 0 | 0 | $0 |
| Jeffrey M Fryer | Chief Financial Officer & Treasurer | 21 mars 2022 P | 47 048 | 0 | 0 | $0 |
| Stephen Uden | Chief Operating Officer & Chief Scientific Officer | 6 février 2023 A | 719 127 | 0 | 0 | $0 |
| Steven Ryder | Chief Medical Officer | 6 février 2023 A | — | 0 | 0 | $0 |
| Wendy Chung | Administrateur | 17 mai 2023 A | — | 0 | 0 | $0 |
| Hui Liu | Administrateur | 17 mai 2023 A | — | 0 | 0 | $0 |
| Paula Soteropoulos | Administrateur | 17 mai 2023 A | — | 0 | 0 | $0 |
| Kush Parmar | Administrateur | 17 mai 2023 A | 2 378 969 | 0 | 0 | $0 |
| Helen M Boudreau | Administrateur | 17 mai 2023 A | — | 0 | 0 | $0 |
| Christine A Nash | Administrateur | 17 mai 2023 A | — | 0 | 0 | $0 |
| Robert Lorne Hopfner | Administrateur | 17 mai 2023 A | 2 267 411 | 0 | 0 | $0 |
| Ronald Hunt | Administrateur | 17 mai 2023 A | 2 301 603 | 0 | 0 | $0 |
| Timothy M Shannon | Administrateur | 3 janvier 2022 A | 2 409 712 | 0 | 0 | $0 |
| FMR LLC | — | 2 août 2021 C | 1 694 388 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 5 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| 5AM Ventures V, L.P., 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Kush Parmar, Scott M. Rocklage ×2 dépôts | 6 mai 2026 | 0,00% | Amendement | — | SEC |
| TPG GP A, LLC, James G. Coulter, Jon Winkelried ×2 dépôts | 3 mars 2026 | 7,20% | Amendement | Fusions et acquisitions / vente | SEC |
| Nan Fung Group Holdings Limited, NF Investment Holdings Limited, Pivotal bioVenture Partners Fund I, L.P., Pivotal bioVenture Partners Fund I G.P., L.P., Pivotal bioVenture Partners Fund I U.G.P. Ltd., Pivotal Partners Ltd, Pivotal Life Sciences Holdings Limited, Nan Fung Life Sciences Holdings Limited ×2 dépôts | 12 février 2024 | — | Dépôt initial | — | SEC |
| 5AM Partners V, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Andrew J. Schwab, Dr. Kush Parmar, Dr. Scott M. Rocklage ×2 dépôts | 7 juin 2022 | — | Dépôt initial | — | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter | 12 août 2021 | — | Dépôt initial | Structure du capital | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 4 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.